The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients

Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition

(2019) Girish S. Naik et al.   Journal for ImmunoTherapy of Cancer

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

(2019) Alessio Cortellini et al.   Journal for ImmunoTherapy of Cancer

Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond

(2018) Jeffrey E. Gershenwald et al.   ANNALS OF SURGICAL ONCOLOGY

Do immune checkpoint inhibitors perform identically in patients with weight extremes?

(2018) Elie El Rassy et al.   Immunotherapy

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

(2018) Jennifer L McQuade et al.   LANCET ONCOLOGY

Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study

(2018) Georg Richtig et al.   PLoS One

The age of enlightenment in melanoma immunotherapy

(2018) Mark R. Albertini   Journal for ImmunoTherapy of Cancer

Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade

(2018) Ziming Wang et al.   NATURE MEDICINE

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

(2017) Jedd D. Wolchok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease

(2014) Un Jung et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Role of obesity on the thickness of primary cutaneous melanoma

(2014) F. Skowron et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Diabetes and cancer: two diseases with obesity as a common risk factor

(2013) S. K. Garg et al.   DIABETES OBESITY & METABOLISM

Obesity and risk of malignant melanoma: A meta-analysis of cohort and case–control studies

(2012) Theodoros N. Sergentanis et al.   EUROPEAN JOURNAL OF CANCER

Population Pharmacokinetics of Therapeutic Monoclonal Antibodies

(2010) Nathanael L. Dirks et al.   CLINICAL PHARMACOKINETICS